Publication:
Presence of lipoprotein lipase S447X stop codon affects the magnitude of interleukin 8 release after cardiac surgery with cardiopulmonary bypass

dc.contributor.authorAK, KORAY
dc.contributor.authorARSAN, SİNAN
dc.contributor.authorsAk, Koray; Isbir, Selim; Tekeli, Atike; Ergen, Arzu; Atalan, Nazan; Dogan, Selami; Civelek, Ali; Arsan, Sinan
dc.date.accessioned2022-03-14T09:07:58Z
dc.date.accessioned2026-01-11T10:41:29Z
dc.date.available2022-03-14T09:07:58Z
dc.date.issued2007-08
dc.description.abstractObjective: Current data suggest that individual genetic predisposition may influence the magnitude of cytokine response and the degree of organ dysfunction after cardiopulmonary bypass. Lipoprotein lipase S447X polymorphism has been shown to be protective against atherosclerosis. The aim of the study was to investigate the effect of lipoprotein lipase S447X polymorphism on cytokine release and early outcome after cardiopulmonary bypass. Methods: Forty patients who underwent coronary artery bypass grafting with cardiopulmonary bypass were included. Genotyping for lipoprotein lipase S447X polymorphism was performed by polymerase chain reaction. Levels of interleukins 6 and 8 were measured before induction and 6, 24, and 72 hours after operation by enzyme-linked immunosorbent assay. Clinical data were collected prospectively. Daily assessment of organ dysfunction was done according to the cardiac surgery scoring ( CASUS) system. Results: The allele frequency of lipoprotein lipase S447X stop codon was 17.5%. S447X carriers revealed significantly lower interleukin 8 levels at the sixth and 24th postoperative hours than the noncarrier group (P = .005 and P = .041, respectively). Patients in the S447X carrier group had significantly shorter ventilation times than the noncarrier group (P = .048). Also, the S447X carrier group revealed significantly lower postoperative 6-hour lactate levels, operative day, and postoperative day 1 organ dysfunction scores than the other group (P =.001, .005 and .002, respectively). Conclusion: Lipoprotein lipase S447X stop codon mutation is associated with lower levels of interleukin 8 after coronary artery bypass grafting. Identification of high-risk patients for cardiopulmonary bypass-related systemic inflammation by detecting lipoprotein lipase S447X stop codon polymorphism may improve early postoperative outcome, especially in patients with limited organ reserves.
dc.identifier.doi10.1016/j.jtcvs.2007.03.017
dc.identifier.issn0022-5223
dc.identifier.pubmed17662793
dc.identifier.urihttps://hdl.handle.net/11424/242603
dc.identifier.wosWOS:000248394700034
dc.language.isoeng
dc.publisherMOSBY-ELSEVIER
dc.relation.ispartofJOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectNECROSIS-FACTOR-ALPHA
dc.subjectINFLAMMATORY RESPONSE
dc.subjectPLASMA TRIGLYCERIDES
dc.subjectINTERFERON-GAMMA
dc.subjectHEART-DISEASE
dc.subjectRISK
dc.subjectGENE
dc.subjectATHEROSCLEROSIS
dc.subjectEXPRESSION
dc.subjectPREDICTS
dc.titlePresence of lipoprotein lipase S447X stop codon affects the magnitude of interleukin 8 release after cardiac surgery with cardiopulmonary bypass
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage483
oaire.citation.issue2
oaire.citation.startPage477
oaire.citation.titleJOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
oaire.citation.volume134

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
file.pdf
Size:
268.71 KB
Format:
Adobe Portable Document Format